- Home
- SGMO vs AFCG Comparison
SGMO vs AFCG Comparison
Compare SGMO & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- AFCG
- Stock Information
- Founded
- SGMO 1995
- AFCG 2020
- Country
- SGMO United States
- AFCG United States
- Employees
- SGMO N/A
- AFCG N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- AFCG Real Estate Investment Trusts
- Sector
- SGMO Health Care
- AFCG Real Estate
- Exchange
- SGMO Nasdaq
- AFCG Nasdaq
- Market Cap
- SGMO 122.8M
- AFCG 127.4M
- IPO Year
- SGMO 2000
- AFCG 2021
- Fundamental
- Price
- SGMO $0.54
- AFCG $4.41
- Analyst Decision
- SGMO Buy
- AFCG Buy
- Analyst Count
- SGMO 6
- AFCG 7
- Target Price
- SGMO $4.50
- AFCG $11.00
- AVG Volume (30 Days)
- SGMO 5.7M
- AFCG 143.4K
- Earning Date
- SGMO 08-12-2025
- AFCG 08-14-2025
- Dividend Yield
- SGMO N/A
- AFCG 20.86%
- EPS Growth
- SGMO N/A
- AFCG 84.02
- EPS
- SGMO N/A
- AFCG 0.96
- Revenue
- SGMO $63,756,000.00
- AFCG $41,036,509.00
- Revenue This Year
- SGMO $1.29
- AFCG N/A
- Revenue Next Year
- SGMO $1.60
- AFCG $17.96
- P/E Ratio
- SGMO N/A
- AFCG $4.61
- Revenue Growth
- SGMO 239.92
- AFCG N/A
- 52 Week Low
- SGMO $0.41
- AFCG $4.32
- 52 Week High
- SGMO $3.18
- AFCG $10.88
- Technical
- Relative Strength Index (RSI)
- SGMO 50.80
- AFCG 41.69
- Support Level
- SGMO $0.50
- AFCG $4.50
- Resistance Level
- SGMO $0.70
- AFCG $4.74
- Average True Range (ATR)
- SGMO 0.05
- AFCG 0.16
- MACD
- SGMO 0.01
- AFCG 0.00
- Stochastic Oscillator
- SGMO 29.17
- AFCG 0.00
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.